PRC Clinical Supports Regenerative Medicine Research

May 26, 2015

Applied Clinical Trials

PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM).

PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM). PRC Clinical has expertise in stem cell and regenerative research working with sponsors in the United States and Israel. Regenerative Medicine is focused on the development and application of cell-based therapies and related technologies to enhance the natural healing process, and/or replace or regenerate organs and tissues. ARM members include Pfizer, Johnson & Johnson and Novartis.

 

Read the full release here.